Harnessing Newton's third-law paradigm to treat autoimmune diseases and chronic inflammations.

Nguyen, Tue Gia

Nguyen, Tue Gia.

Affiliation

Nguyen TG; IgD Mab Technology (IMT) Group, Sydney, NSW, 2113, Australia. ceo-imt@igdmabtech.com.

Inflamm Res ; 69(9): 813-824, 2020 Sep.

Article in En | MEDLINE | ID: mdl-32591922

Subject(s)

Autoimmune Diseases/drug therapy; Inflammation/drug therapy; Adaptive Immunity; Animals; Autoimmune Diseases/immunology; Homeostasis; Humans; Immune Tolerance; Immunity, Innate; Immunotherapy; Inflammation/immunology; Receptors, Antigen, B-Cell/physiology; Receptors, Antigen, T-Cell/physiology; Toll-Like Receptor 4/physiology

Key words

Adaptive immunity; Allergy; Autoimmune diseases; B cells; IgD; Immune tolerance; Immunomodulation; Immunotherapy; Inflammation; Innate immunity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Autoimmune Diseases / Inflammation Limits: Animals / Humans Language: En Journal: Inflamm Res Journal subject: ALERGIA E IMUNOLOGIA / PATOLOGIA Year: 2020 Type: Article Affiliation country: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google